Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology

NCT03294941 is registered in ClinicalTrials.gov with HepQuant, LLC as lead sponsor.

NCT NCT03294941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03294941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology
Lead sponsor
HepQuant, LLC
Phase
Phase 2
Overall status
Terminated
Start date
December 8, 2017
Completion date
September 11, 2019
Enrollment
17 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

nash - nonalcoholic steatohepatitis